Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 1,157

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

Saag, Kenneth G., Teng, Gim Gee, Patkar, Nivedita M., Anuntiyo, Jeremy, Finney, Catherine, Curtis, Jeffrey R., Paulus, Harold E., Mudano, Amy, Pisu, Maria, Elkins‐Melton, Mary, Outman, Ryan, Allison, Jeroan J., Almazor, Maria Suarez, Bridges, S. Louis, Chatham, W. Winn, Hochberg, Marc, Maclean, Catherine, Mikuls, Ted, Moreland, Larry W., O'dell, James, Turkiewicz, Anthony M., Furst, Daniel E.·2008·Arthritis Care & Research
DOI 10.1002/art.23721
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.23721

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 248

  1. 10.1001/jama.289.24.3229 · DOI
  2. 10.1056/NEJMct055183 · DOI · Paper page
  3. 10.1002/art.10148 · DOI · Paper page
  4. Fitch K, 2001, The RAND/UCLA Appropriateness Method user's manual
  5. Wells GA, 1999, The Newcastle‐Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta‐analyses
  6. 10.1136/ard.2004.028886 · DOI · Paper page
  7. 10.1002/art.21235 · DOI · Paper page
  8. 10.1002/art.1780380602 · DOI · Paper page
  9. Pincus T, 2005, The American College of Rheumatology (ACR) core data set and derivative “patient only” indices to assess rheumatoid arthritis, Clin Exp Rheumatol, 23, S109
  10. Wells GA, 2005, Minimal disease activity for rheumatoid arthritis: a preliminary definition, J Rheumatol, 32, 2016
  11. Wolfe F, 2005, A composite disease activity scale for clinical practice, observational studies, and clinical trials: the Patient Activity Scale (PAS/PAS‐II), J Rheumatol, 32, 2410
  12. 10.1002/art.21494 · DOI
  13. 10.1007/s10067-006-0275-5 · DOI
  14. 10.1007/s10067-006-0343-x · DOI
  15. 10.1136/ard.2005.041376 · DOI · Paper page
  16. 10.1136/ard.62.2.120 · DOI · Paper page
  17. 10.1136/ard.62.5.427 · DOI
  18. 10.1136/ard.61.4.290 · DOI · Paper page
  19. 10.1136/ard.2003.010611 · DOI
  20. 10.1136/ard.62.7.611 · DOI
  21. 10.1136/ard.61.12.1055 · DOI
  22. 10.1136/ard.36.3.274 · DOI
  23. Cohen JD, 2006, Health Assessment Questionnaire score is the best predictor of 5‐year quality of life in early rheumatoid arthritis, J Rheumatol, 33, 1936
  24. 10.1093/rheumatology/32.8.717 · DOI
  25. 10.1136/ard.45.5.373 · DOI
  26. 10.1002/1529-0131(199809)41:9<1571::AID-ART7>3.0.CO;2-R · DOI
  27. 10.1002/1529-0131(199806)41:6<1072::AID-ART14>3.0.CO;2-G · DOI
  28. 10.1093/rheumatology/32.10.899 · DOI
  29. 10.1016/j.jamcollsurg.2005.07.009 · DOI
  30. 10.1177/0272989X04264212 · DOI
  31. 10.1016/S0895-4356(01)00365-1 · DOI
  32. Hunt SA, 2005, ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure), Circulation, 112, e154
  33. 10.1093/rheumatology/kei024 · DOI
  34. 10.1185/030079906X80341 · DOI
  35. Wendt T, 1999, Influence of methotrexate and azathioprine on radiologic progression in rheumatoid arthritis, Eur J Med Res, 4, 442
  36. 10.1002/art.1780340805 · DOI
  37. 10.1002/art.21018 · DOI
  38. 10.1016/0049-0172(91)90047-4 · DOI
  39. Rau R, 1991, A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis, J Rheumatol, 18, 328
  40. 10.1136/ard.58.4.220 · DOI · Paper page
  41. 10.1093/rheumatology/36.10.1082 · DOI
  42. 10.1002/art.1780350802 · DOI
  43. 10.1093/rheumatology/33.11.1049 · DOI
  44. 10.1056/NEJM199605163342002 · DOI
  45. 10.1001/archinte.159.21.2542 · DOI · Paper page
  46. 10.7326/0003-4819-137-9-200211050-00007 · DOI · Paper page
  47. 10.1002/art.1780381111 · DOI · Paper page
  48. 10.1016/S0140-6736(98)09403-3 · DOI · Paper page
  49. 10.1093/rheumatology/30.6.451 · DOI
  50. 10.1016/S0002-9343(99)80399-4 · DOI
  51. 10.7326/0003-4819-119-11-199312010-00002 · DOI
  52. 10.1002/1529-0131(200110)44:10<2235::AID-ART385>3.0.CO;2-A · DOI
  53. 10.1136/ard.48.5.389 · DOI
  54. 10.7326/0003-4819-122-2-199501150-00001 · DOI · Paper page
  55. 10.1002/art.1780370505 · DOI
  56. 10.1002/art.1780400510 · DOI
  57. 10.1002/art.1780310602 · DOI
  58. 10.1136/ard.60.10.913 · DOI
  59. Kalden JR, 2001, Improved functional ability in patients with rheumatoid arthritis: longterm treatment with leflunomide versus sulfasalazine, J Rheumatol, 28, 1983
  60. The Australian Multicentre Clinical Trial Group, 1992, Sulfasalazine in early rheumatoid arthritis, J Rheumatol, 19, 1672
  61. 10.1007/BF02208150 · DOI
  62. 10.1002/art.10228 · DOI
  63. Hurst S, 2002, Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects, J Rheumatol, 29, 1639
  64. 10.1016/S0140-6736(97)01300-7 · DOI · Paper page
  65. 10.1002/art.21519 · DOI · Paper page
  66. 10.1002/art.20712 · DOI · Paper page
  67. 10.1002/art.20568 · DOI · Paper page
  68. 10.7326/0003-4819-146-6-200703200-00005 · DOI · Paper page
  69. 10.1056/NEJM200011303432201 · DOI · Paper page
  70. 10.1002/art.21405 · DOI · Paper page
  71. 10.1002/art.10308 · DOI · Paper page
  72. Baumgartner SW, 2004, Etanercept (Enbrel) in patients with rheumatoid arthritis with recent onset versus established disease: improvement in disability, J Rheumatol, 31, 1532
  73. Genovese MC, 2005, Longterm safety, efficacy, and radiographic outcome with etanercept treatment in patients with early rheumatoid arthritis, J Rheumatol, 32, 1232
  74. 10.1002/1529-0131(200010)43:10<2316::AID-ANR20>3.0.CO;2-6 · DOI
  75. 10.1016/S0002-9343(02)01243-3 · DOI
  76. Choi HK, 2002, A cost effectiveness analysis of treatment options for methotrexate‐naive rheumatoid arthritis, J Rheumatol, 29, 1156
  77. 10.1136/ard.2005.038349 · DOI
  78. 10.1016/S0140-6736(04)15640-7 · DOI · Paper page
  79. 10.1002/art.11142 · DOI
  80. 10.7326/0003-4819-130-6-199903160-00004 · DOI · Paper page
  81. 10.1196/annals.1254.057 · DOI
  82. O'Dell JR, 2006, Etanercept in combination with sulfasalazine, hydroxychloroquine, or gold in the treatment of rheumatoid arthritis, J Rheumatol, 33, 213
  83. 10.1111/j.1445-5994.2006.01170.x · DOI
  84. 10.1002/art.11027 · DOI
  85. 10.1136/ard.2005.035709 · DOI
  86. 10.1136/ard.2003.013052 · DOI · Paper page
  87. 10.1016/S0149-2918(03)80164-9 · DOI · Paper page
  88. 10.1136/ard.61.4.358 · DOI
  89. 10.1093/rheumatology/keh508 · DOI
  90. Furst DE, 2003, Adalimumab, a fully human anti tumor necrosis factor‐α monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis), J Rheumatol, 30, 2563
  91. 10.1002/art.20228 · DOI
  92. 10.1136/ard.2006.051540 · DOI
  93. 10.1002/art.20217 · DOI · Paper page
  94. 10.1016/S0140-6736(99)05246-0 · DOI · Paper page
  95. 10.1002/1529-0131(199809)41:9<1552::AID-ART5>3.0.CO;2-W · DOI
  96. 10.1002/art.20159 · DOI · Paper page
  97. 10.1136/ard.2003.015933 · DOI
  98. 10.1016/j.amjmed.2005.01.029 · DOI
  99. 10.1056/NEJM200011303432202 · DOI · Paper page
  100. 10.1002/art.20982 · DOI · Paper page
  101. 10.1002/art.21655 · DOI · Paper page
  102. 10.1056/NEJM199901283400401 · DOI · Paper page
  103. 10.1136/ard.2005.044404 · DOI
  104. 10.1002/art.10697 · DOI · Paper page
  105. 10.1002/art.20221 · DOI · Paper page
  106. 10.1136/ard.2005.049650 · DOI
  107. Emery P, 2006, Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health‐related quality of life, J Rheumatol, 33, 681
  108. Genant HK, 2006, Abatacept sustains inhibition of radiographic progression over 2 years in rheumatoid arthritis patients with an inadequate response to methotrexate: results from the long‐term extension of the AIM trial, Ann Rheum Dis, 65, 57
  109. 10.7326/0003-4819-144-12-200606200-00003 · DOI · Paper page
  110. 10.1002/art.21778 · DOI · Paper page
  111. 10.1136/ard.2004.029694 · DOI · Paper page
  112. 10.1002/art.22070 · DOI · Paper page
  113. 10.1002/art.21978 · DOI · Paper page
  114. 10.1002/art.21568 · DOI · Paper page
  115. 10.1002/art.20009 · DOI · Paper page
  116. 10.1001/jama.295.19.2275 · DOI · Paper page
  117. 10.1002/art.21386 · DOI · Paper page
  118. 10.1002/art.21137 · DOI · Paper page
  119. 10.1016/S0755-4982(05)83925-9 · DOI
  120. 10.1086/506935 · DOI · Paper page
  121. 10.1136/ard.62.suppl_2.ii30 · DOI
  122. 10.1056/NEJMoa011110 · DOI · Paper page
  123. 10.1086/421494 · DOI · Paper page
  124. Perdriger A, 2006, Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice, J Rheumatol, 33, 865
  125. 10.1136/ard.2005.043166 · DOI · Paper page
  126. McKendry RJ, 1988, Toxicity of methotrexate compared with azathioprine in the treatment of rheumatoid arthritis: a case‐control study of 131 patients, Arch Intern Med, 149, 685, 10.1001/archinte.1989.00390030137027 · DOI
  127. 10.1093/rheumatology/39.12.1374 · DOI
  128. 10.1093/rheumatology/39.6.655 · DOI · Paper page
  129. 10.1093/rheumatology/keh512 · DOI
  130. 10.1007/BF02114393 · DOI
  131. 10.1093/rheumatology/28.2.147 · DOI
  132. 10.1007/BF00302669 · DOI
  133. Buchbinder R, 1993, Methotrexate therapy in rheumatoid arthritis: a life table review of 587 patients treated in community practice, J Rheumatol, 20, 639
  134. 10.1378/chest.109.4.933 · DOI
  135. 10.1093/rheumatology/35.5.441 · DOI
  136. Ohosone Y, 1997, Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis, J Rheumatol, 24, 2299
  137. 10.1002/art.1780290713 · DOI
  138. Tan N, 1993, Oral methotrexate in the treatment of Felty's syndrome, J Rheumatol, 20, 599
  139. 10.1093/rheumatology/37.8.908 · DOI
  140. 10.1136/ard.2004.033241 · DOI · Paper page
  141. 10.1136/ard.2004.023473 · DOI
  142. 10.1136/ard.2004.030528 · DOI · Paper page
  143. 10.1136/ard.61.9.793 · DOI · Paper page
  144. Louis M, 2003, Induction of autoantibodies during prolonged treatment with infliximab, J Rheumatol, 30, 2557
  145. 10.1002/art.20311 · DOI · Paper page
  146. The Criteria Committee of the New York Heart Association, 1994, Nomenclature and criteria for diagnosis of diseases of the heart and great vessels, 253
  147. 10.1161/01.CIR.0000077913.60364.D2 · DOI · Paper page
  148. 10.1161/01.CIR.0000124490.27666.B2 · DOI · Paper page
  149. 10.1080/030097499750042245 · DOI
  150. 10.1002/1529-0131(200109)44:9<1984::AID-ART346>3.0.CO;2-B · DOI
  151. Cartwright VW, 2003, Methotrexate, laboratory testing and risk of serious illness: analyses in 20,000 patients, Arthritis Rheum, 48, S428
  152. Rau R, 1989, Liver biopsy findings in patients with rheumatoid arthritis undergoing longterm treatment with methotrexate, J Rheumatol, 16, 489
  153. Yazici Y, 2005, Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities, Clin Exp Rheumatol, 23, 517
  154. 10.1136/ard.2004.023408 · DOI
  155. 10.1093/rheumatology/29.2.120 · DOI
  156. 10.1136/ard.60.6.566 · DOI
  157. Morassut P, 1989, Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis: a randomized, double blind 26‐week trial, J Rheumatol, 16, 302
  158. Suarez‐Almazor ME, 1988, A randomized controlled trial of parenteral methotrexate compared with sodium aurothiomalate (Myochrysine) in the treatment of rheumatoid arthritis, J Rheumatol, 15, 753
  159. 10.1002/art.1780360303 · DOI
  160. 10.1093/rheumatology/36.3.345 · DOI
  161. 10.1093/rheumatology/37.10.1060 · DOI
  162. Cannon GW, 2004, Adverse events with disease modifying antirheumatic drugs (DMARD): a cohort study of leflunomide compared with other DMARD, J Rheumatol, 31, 1906
  163. 10.1002/art.20167 · DOI
  164. Sany J, 1991, Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 cases, J Rheumatol, 18, 1323
  165. 10.1002/art.1780330305 · DOI
  166. 10.1007/BF02030344 · DOI
  167. 10.1136/ard.47.8.654 · DOI
  168. 10.1007/BF02330596 · DOI
  169. 10.1016/0002-9343(85)90312-2 · DOI
  170. 10.1002/art.1780371013 · DOI
  171. McKendry RJ, 1993, Adverse effects of low dose methotrexate therapy in rheumatoid arthritis, J Rheumatol, 20, 1850
  172. 10.1007/BF00290521 · DOI
  173. Andersen LS, 1997, Prospectively measured red cell folate levels in methotrexate treated patients with rheumatoid arthritis: relation to withdrawal and side effects, J Rheumatol, 24, 830
  174. 10.1093/rheumatology/33.7.651 · DOI
  175. 10.1136/ard.62.4.291 · DOI
  176. 10.3109/03009749509095176 · DOI
  177. Jones E, 1991, Response to sulfasalazine in rheumatoid arthritis: life table analysis of a 5‐year followup, J Rheumatol, 18, 195
  178. 10.1002/hep.1840040313 · DOI · Paper page
  179. 10.1016/S0011-3840(64)80003-4 · DOI
  180. 10.1007/s10067-006-0218-1 · DOI
  181. 10.1136/gut.35.4.569 · DOI
  182. Koziel MJ, 1992, Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis, J Immunol, 149, 3339, 10.4049/jimmunol.149.10.3339 · DOI · Paper page
  183. 10.1111/j.1478-3231.2006.01339.x · DOI
  184. 10.1128/JVI.77.4.2469-2476.2003 · DOI
  185. 10.1111/j.1440-1746.2006.04559.x · DOI
  186. Nagashima M, 2005, The ability of disease modifying antirheumatic drugs to induce and maintain improvement in patients with rheumatoid arthritis: epidemiology of DMARDs treatment in Japan, Clin Exp Rheumatol, 23, 27
  187. Furst DE, 1989, Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis, J Rheumatol, 16, 313
  188. Ostensen M, 2006, Anti‐inflammatory and immunosuppressive drugs and reproduction, Arthritis Res Ther, 8, 209, 10.1186/ar1957 · DOI
  189. 10.3109/00016348709022049 · DOI
  190. 10.1046/j.1365-2133.1996.134869.x · DOI
  191. 10.1016/0002-9378(72)90824-1 · DOI
  192. 10.1038/ncprheum0532 · DOI
  193. Chakravarty EF, 2003, The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes, J Rheumatol, 30, 241
  194. 10.1007/s10620-006-9452-2 · DOI
  195. 10.1111/j.1572-0241.2004.30186.x · DOI · Paper page
  196. 10.1111/j.1365-2036.2005.02405.x · DOI · Paper page
  197. 10.1038/sj.jp.7211481 · DOI
  198. 10.1093/rheumatology/kel400 · DOI
  199. 10.1034/j.1600-0897.2001.d01-25.x · DOI
  200. 10.1016/j.semarthrit.2005.05.002 · DOI

200 of 248 shown

Cited by

Metadata

Authors
Saag, K. G., Teng, G. G., Patkar, N. M., Anuntiyo, J., Finney, C., Curtis, J. R., Paulus, H. E., Mudano, A., Pisu, M., Elkins‐Melton, M., Outman, R., Allison, J. J., Almazor, M. S., Bridges, S. L., Chatham, W. W., Hochberg, M., Maclean, C., Mikuls, T., Moreland, L. W., O'dell, J., Turkiewicz, A. M., & Furst, D. E.
Venue
Arthritis Care & Research
Publisher
Wiley
Published
2008-05-30
Volume
59
Issue
6
Pages
762-784
ISSN
  • 0893-7524
  • 1529-0123
DOI
10.1002/art.23721
Cited by
1,157
References
6
Language
en
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.